• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?
RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.


REVIEW OF: Mahr F et al, J Child Adolesc Psychopharmacol 2022;32(2): 117–121 

STUDY TYPE: Retrospective chart review 

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID. 

Researchers reviewed the charts of 53 children and teens with ARFID treated in a partial hospital program. These charts were selected because the patients were given either SSRIs only or SSRIs with hydroxyzine as part of their treatment. The group was largely pubertal females with body mass index (BMI) of 15–16. To track progress with weight gain, this study followed the percent median body mass index, or %MBMI: the patient’s BMI divided by the median BMI for their age, then multiplied by 100. A typical goal is for patients to achieve a %MBMI of 90 to consider the treatment clinically meaningful. 

All patients had significant anxiety. Those who took hydroxyzine in addition to SSRIs were older than those who did not (13 vs 11), were made up of fewer female patients (64% vs 92%), and had more depressive symptoms on the Child Depression Inventory (62 vs 53). All patients benefited from SSRIs, with reduced anxiety, depression, and fear of eating. Patients in both categories improved weight gain, with those on SSRIs alone experiencing a %MBMI increase from 88 to 96 over the course of a year, and those who received SSRIs + hydroxyzine up from 89 to 98 over the same period. Hydroxyzine also helped subjective fear of eating as well as nausea in the more severe cohort of patients who received both medications. Side effects included mild sedation and fatigue for hydroxyzine and headache for SSRIs. 

The authors suggest starting SSRIs at 5 mg of fluoxetine (or equivalent) and titrating slowly to prevent paradoxically increasing anxiety. Hydroxyzine takes 15–30 minutes to act and peaks around two hours. The authors recommend dosing 0.5 mg/kg every four to six hours as needed for anxiety. Hydroxyzine liquid is helpful for patients who have trouble swallowing pills. 

Carlat Take
While this was a small uncontrolled study of patients in a relatively high level of care, it reminds us to assess for anxiety in ARFID. Of course, we need more research, but in the meantime SSRIs may help anxiety in ARFID, and adding hydroxyzine to an SSRI may help in severe cases of ARFID with comorbid symptoms.

Child Psychiatry
KEYWORDS ARFID child psychiatry eating disorders hydroxyzine research update ssris
Eic photo joshua d feder md jpg 150x150
Joshua Feder, MD

Assessment of Non-Suicidal Self-Injury in Children and Adolescents

More from this author
www.thecarlatreport.com
Issue Date: October 1, 2022
SUBSCRIBE NOW
Table Of Contents
Note From the Editor-in-Chief
Bipolar Spectrum Disorders in Children and Adolescents
Assessing and Treating Catatonia in Children and Adolescents
Assessing Sensory Processing Challenges
Consider Catatonia in Your Differential
SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?
Pediatric Bipolar Depression: How Do We Rate a New Meta-Analysis?
Ask the Editor: Is Silexan Safe for Children and Adolescents?
CME Post-Test, Catatonia in Children and Adolescents, CCPR, Oct/Nov/Dec 2022
DOWNLOAD NOW
Featured Book
  • CMFB2e_Cover.png

    Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • teen_depression.jpeg
    Child Psychiatry

    Assessment of Non-Suicidal Self-Injury in Children and Adolescents

    Learn how to assess and intervene with NSSI, including ideas for supporting autonomy while addressing the behavior.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.